Healthcare -
Biotechnology - NASDAQ - US
$ 7.37
3.08 %
$ 365 M
Market Cap
-1.47
P/E
RGNX - LONG-TERM DEBT
Long-term Debt RGNX - REGENXBIO Inc.
82.2 M
LAST VALUE
-1.61%
2 YEAR CAGR
69.63%
5 YEAR CAGR
0.00%
10 YEAR CAGR